Brief: Vincerx Pharma Publishes Preclinical Data Demonstrating Therapeutic Potential Of Small Molecule-Drug Conjugate Vip236 In The Journal Cancers
03/02/2022 13:35
Feb 3 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA PUBLISHES PRECLINICAL DATA DEMONSTRATING
THERAPEUTIC POTENTIAL OF SMALL MOLECULE-DRUG CONJUGATE VIP236 IN
THE JOURNAL CANCERS
Source text for Eikon: ID:nGNX6mj8Ws
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign